PMID- 16123537 OWN - NLM STAT- MEDLINE DCOM- 20051025 LR - 20060328 IS - 1534-0384 (Print) IS - 1534-0384 (Linking) VI - 5 IP - 4 DP - 2005 Aug TI - Hanging in the balance. KIR and their role in disease. PG - 226-40 AB - The killer cell immunoglobulin-like receptors (KIR) are a recently discovered family of activating and inhibitory receptors that control natural killer (NK) cell function. KIR exist as a diverse family of receptors that have evolved rapidly by both gene duplication and recombination events. These findings were unexpected for a family of genes involved primarily in the innate immune response. These findings together with the observation that several of these genes have human leukocyte antigen (HLA) class I ligands, have led to a flurry of investigation into how KIR participate in viral infections, autoimmune diseases and malignancies. This review summarizes the major features of these genes and discusses how they may be involved in both disease pathogenesis and its amelioration. FAU - Williams, Anthony P AU - Williams AP AD - Division of Cancer Sciences, Southampton University School of Medicine, Southampton, UK, SO16 6YD. apw2@soton.ac.uk FAU - Bateman, Andrew R AU - Bateman AR FAU - Khakoo, Salim I AU - Khakoo SI LA - eng PT - Journal Article PT - Review PL - United States TA - Mol Interv JT - Molecular interventions JID - 101093789 RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Receptors, Immunologic) SB - IM MH - Animals MH - Autoimmune Diseases/immunology MH - Cytomegalovirus Infections/immunology MH - Evolution, Molecular MH - Female MH - Genotype MH - HIV Infections/immunology MH - HLA Antigens MH - Hematologic Diseases/immunology MH - Hepatitis C/immunology MH - Histocompatibility Antigens Class I MH - Humans MH - Immune System/physiology MH - Killer Cells, Natural/*metabolism MH - Multigene Family MH - Neoplasms/immunology MH - Pregnancy MH - *Receptors, Immunologic/genetics/metabolism RF - 130 EDAT- 2005/08/27 09:00 MHDA- 2005/10/26 09:00 CRDT- 2005/08/27 09:00 PHST- 2005/08/27 09:00 [pubmed] PHST- 2005/10/26 09:00 [medline] PHST- 2005/08/27 09:00 [entrez] AID - 5/4/226 [pii] AID - 10.1124/mi.5.4.6 [doi] PST - ppublish SO - Mol Interv. 2005 Aug;5(4):226-40. doi: 10.1124/mi.5.4.6.